S. Haffner

Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay

K. Polonsky, D. Porte, R. Chance, 1996, Diabetes.

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

S. Grundy, P. Barter, D. Waters, 2006, The Lancet.

Hyperglycemia as a cardiovascular risk factor.

S. Haffner, H. Cassells, Steven Haffner, 2003, The American journal of medicine.

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.

B. Kasiske, H. Parving, P. Bennett, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.

R. Frye, G. Bakris, W. Hsueh, 2005, Metabolic syndrome and related disorders.